PanTherix Enters Agreement with Genome Therapeutics to Determine Essential Structural Information for Anti-Infective Targets and Leads GLASGOW, Scotland, Jan. 23, 2003 (PRIMEZONE) -- PanTherix Ltd. today announced that it has entered a research agreement with Genome Therapeutics (Nasdaq:GENE), to support Genome Therapeutics' lead...